US Patent Issued to EDITAS MEDICINE on June 10 for "Crispr-CPF1-related methods, compositions and components for cancer immunotherapy" (Massachusetts Inventors)

ALEXANDRIA, Va., June 18 -- United States Patent no. 12,325,854, issued on June 10, was assigned to EDITAS MEDICINE INC. (Cambridge, Mass.).

"Crispr-CPF1-related methods, compositions and components for cancer immunotherapy" was invented by Gordon Grant Welstead (Cambridge, Mass.), Hariharan Jayaram (Cambridge, Mass.), Tongyao Wang (Malden, Mass.), John Anthony Zuris (Cambridge, Mass.) and Christopher Borges (Reading, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "CRISPR/Cpf1-related compositions and methods for treatment of cancer."

The patent was filed on Sept. 4, 2018, under Application No. 16/121,152.

*For further information, including images, charts and tables, please visit: http://patft.uspto....